Keyphrases
Disease Activity
100%
Radiographic Progression
75%
Surface Expression
75%
Monocytes
75%
Systemic Lupus Erythematosus Patient
75%
Early Rheumatoid Arthritis
75%
β2-microglobulin (β2-MG)
75%
Clinical Markers
75%
Rheumatoid Arthritis Patients
50%
Systemic Lupus Erythematosus
37%
CD4+ T Lymphocytes
24%
Disease Duration
24%
Circulating Monocytes
24%
Disease-modifying Antirheumatic Drugs (DMARDs)
24%
Nave
24%
Interleukin-10
18%
Complement C3
18%
IFN-stimulated Genes
18%
Interleukin-8
18%
Interleukin-18 (IL-18)
18%
Proteinuria
18%
Serum Levels
18%
Immunology and Microbiology
Inflammatory Arthritis
75%
Systemic Lupus Erythematosus
75%
Cell Surface
75%
Blood Plasma
75%
C-C Chemokine Receptor Type 7
75%
Macrophage Inflammatory Protein 3beta
75%
CD4+ T Lymphocyte
24%
Disease-Modifying Antirheumatic Drug
24%
Cytokine
21%
Complement Component 3
21%
Interleukin 10
21%
Interleukin 6
21%
Interleukin 18
21%
Interleukin 8
21%
Blood Level
21%
Biochemistry, Genetics and Molecular Biology
Microglobulin
75%
Interleukin 18
18%
Interleukin 6
18%
Cytokine
18%
Complement Component 3
18%
Interleukin 10
18%
Interleukin 8
18%
Blood Level
18%
